SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

Search

Fagron

Uždarymo kaina

SektoriusSveikatos priežiūra

25.15 0.8

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

24.95

Max

25.15

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-99K

45M

Pardavimai

-98K

476M

P/E

Sektoriaus vid.

19.597

49.701

Dividendų pajamingumas

1.66

Pelno marža

9.55

Darbuotojai

4,193

EBITDA

11M

98M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+20.59% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.66%

2.39%

Kitas uždarbis

2026-07-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

153M

1.8B

Ankstesnė atidarymo kaina

24.35

Ankstesnė uždarymo kaina

25.15

Naujienos nuotaikos

By Acuity

50%

50%

151 / 345 reitingas Healthcare

Fagron Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-05-24 23:46; UTC

Rinkos pokalbiai

Pullback in Oil Prices Could Temper Inflation Expectations -- Market Talk

2026-05-24 23:45; UTC

Rinkos pokalbiai

Gold, Silver Rise on Hopes for U.S.-Iran Deal -- Market Talk

2026-05-24 23:42; UTC

Rinkos pokalbiai

Mineral Resources Bull More Positive Post Site Visit -- Market Talk

2026-05-24 23:34; UTC

Rinkos pokalbiai

Oil Falls Amid Prospects for Reopening of Strait of Hormuz -- Market Talk

2026-05-24 23:11; UTC

Rinkos pokalbiai

RBNZ Likely to Stand Pat But Watch for Dissent -- Market Talk

2026-05-24 22:26; UTC

Įsigijimai, susijungimai, perėmimai

Beach Energy: La Bella 2 Will No Longer Be Drilled as Part of Equinox Campaign

2026-05-24 22:25; UTC

Įsigijimai, susijungimai, perėmimai

Beach Energy: Implied Transaction Value of Around A$130 Million After Tax

2026-05-24 22:25; UTC

Įsigijimai, susijungimai, perėmimai

Beach Energy: Royalty Payments Likely to Total Around A$140 Million Based on Resource Booking

2026-05-24 22:24; UTC

Įsigijimai, susijungimai, perėmimai

Beach Energy to Get Production Royalty of A$3.75/GJ in Deal

2026-05-24 22:24; UTC

Įsigijimai, susijungimai, perėmimai

Beach Energy to Get A$70 Million Cash Proceeds When Deal Completes

2026-05-24 22:23; UTC

Įsigijimai, susijungimai, perėmimai

Beach Energy Says Deal Includes Artisan Natural-Gas Discovery

2026-05-24 22:23; UTC

Įsigijimai, susijungimai, perėmimai

Beach Energy Sells 60% Operated Interest in VIC/L35 Block in Otway Basin

2026-05-24 22:11; UTC

Rinkos pokalbiai

Oil Price Unlikely to Return to Pre-Conflict Levels This Year -- Market Talk

2026-05-24 22:04; UTC

Rinkos pokalbiai

Oil Price Likely Lower, Equities Higher on Iran Deal Talks Progress -- Market Talk

2026-05-23 08:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-05-23 08:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-05-22 21:10; UTC

Uždarbis

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

2026-05-22 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-05-22 20:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-05-22 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-05-22 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-05-22 19:47; UTC

Uždarbis

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

2026-05-22 19:17; UTC

Rinkos pokalbiai

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

2026-05-22 19:10; UTC

Rinkos pokalbiai

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

2026-05-22 18:54; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-05-22 18:54; UTC

Rinkos pokalbiai

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

2026-05-22 18:38; UTC

Rinkos pokalbiai

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

2026-05-22 18:35; UTC

Įsigijimai, susijungimai, perėmimai

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

2026-05-22 18:09; UTC

Rinkos pokalbiai

Centralized Crypto Lending Slows in 1Q -- Market Talk

2026-05-22 17:58; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

Akcijų palyginimas

Kainos pokytis

Fagron Prognozė

Kainos tikslas

By TipRanks

20.59% į viršų

12 mėnesių prognozė

Vidutinis 19.5 EUR  20.59%

Aukščiausias 19.5 EUR

Žemiausias 19.5 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fagron kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

151 / 345 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat